IRL
The New Ireland Fund, Inc. [IRL] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
IRL Stock Summary
In the News
IRL Financial details
Company Rating
-
Market Cap
37.76M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
24 Jun 2019
P/E
0
Forward P/E
-
PEG
-
P/S
-2.69
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
6.55%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
14.24%
Inst Trans
0.34%
ROA
-47%
ROE
-35%
ROC
-0.47%
Gross Margin
100%
Oper. Margin
107%
Profit Margin
107%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.12-10.75
52W High
-
52W Low
-
RSI
50
Rel Volume
1
Avg Volume
24.93K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.14156
-
-
Volatility
0.04%, 0.04%
Prev Close
-
Price
-
Change
-
IRL Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-10-31
| Metric | History | 2018-10-31 | 2019-10-31 | 2020-10-31 | 2021-10-31 | 2022-10-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | -2.06 | 0.59 | -0.19 | 6.37 | 0 | |
| Net income per share | -2.24 | 0.44 | -0.34 | 6.19 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0.26 | 0.08 | 0.07 | 0.04 | 0 | |
| Book value per share | 11.08 | 10.82 | 11.56 | 15.17 | 0 | |
| Tangible book value per share | 11.08 | 10.85 | 11.6 | 15.22 | 0 | |
| Share holders equity per share | 11.08 | 10.82 | 11.56 | 15.17 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 45.69M | 45.84M | 35.93M | 46.48M | 0 | |
| Enterprise value | 44.41M | 45.44M | 35.63M | 46.35M | -698.87K | |
| P/E ratio | -4.1 | 20.59 | -23.09 | 2.06 | 0 | |
| Price to sales ratio | -4.47 | 15.26 | -41.19 | 2.01 | 0 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0.83 | 0.84 | 0.68 | 0.84 | 0 | |
| PTB ratio | 0.83 | 0.84 | 0.68 | 0.84 | 0 | |
| EV to sales | -4.34 | 15.13 | -40.84 | 2 | 0.05 | |
| Enterprise value over EBITDA | -3.98 | 20.41 | -22.89 | 2.06 | 0.05 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | -0.24 | 0.05 | -0.04 | 0.48 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 0.11 | -0.18 | 0.2 | -0.01 | 0.05 | |
| Current ratio | 43.12 | 17.01 | 3.82 | 1.98 | 0 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | -0.07 | 0.23 | -0.7 | 0.03 | -0.06 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 23.63 | 10.35 | 9.4 | 45.96 | 0 | |
| ROIC | -0.2 | 0.04 | -0.03 | 0.41 | -0.47 | |
| Return on tangible assets | -0.2 | 0.04 | -0.03 | 0.4 | -0.47 | |
| Graham Net | 0.23 | 0.09 | 0.05 | 0.06 | 0 | |
| Working capital | 1.31M | 467.47K | 252.15K | 352.74K | 910.64K | |
| Tangible asset value | 55.16M | 54.91M | 53.08M | 55.39M | 31.9M | |
| Net current asset value | 1.17M | 467.47K | 252.15K | 352.74K | 910.64K | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 101.9K | 81.8K | 65.18K | 307.39K | 395.12K | |
| Average payables | 46.73K | 30.14K | 59.24K | 225.27K | 180.63K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | -2.48 | 11.43 | -15.19 | 9.11 | -5.5 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | -147.07 | 31.93 | -24.03 | 40.07 | -66.34 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -0.2 | 0.04 | -0.03 | 0.41 | -0.47 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-10-31 for Q4
| Metric | History | 2020-10-31 | 2021-04-30 | 2021-10-31 | 2022-04-30 | 2022-10-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value | -305.13K | -608.7K | -135.52K | -201.05K | -698.87K | |
| P/E ratio | 0 | 0 | 0 | 0 | 0 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
| PTB ratio | 0 | 0 | 0 | 0 | 0 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
| Current ratio | 3.82 | 0 | 1.98 | 0 | 0 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | 0 | 0 | 0 | 0 | 0 | |
| Working capital | 252.15K | 1.04M | 352.74K | 681.04K | 910.64K | |
| Tangible asset value | 52.91M | 72.78M | 55.21M | 36.42M | 31.9M | |
| Net current asset value | 74.78K | 772.73K | 176.63K | 499.94K | 910.64K | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 46.66K | 235.72K | 506.8K | 529.23K | 345.88K | |
| Average payables | 67.08K | 44.64K | 180.63K | 180.63K | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0 | 0 | 0 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
IRL Frequently Asked Questions
What is The New Ireland Fund, Inc. stock symbol ?
The New Ireland Fund, Inc. is a US stock , located in Boston of Ma and trading under the symbol IRL
What is The New Ireland Fund, Inc. stock quote today ?
The New Ireland Fund, Inc. stock price is $- today.
Is The New Ireland Fund, Inc. stock public?
Yes, The New Ireland Fund, Inc. is a publicly traded company.
Company Profile
- Volume Average 24.93K
- Market Capitalization 37.76M
- CEO Mr. Sean Michael Hawkshaw
- Headquarters Boston,MA,US
- IPO Date 2009-01-01
-
Website
https://www.newirelandfund.com 
The New Ireland Fund, Inc. is a close-ended balanced mutual fund launched by Bank of Ireland Asset Management (U.S.) Limited. It is managed by Kleinwort Benson Investors International Ltd. The fund invests in the public equity and fixed income markets of the Ireland. It seeks to invest in growth stocks of companies operating across diversified sectors. The fund benchmarks the performance of its portfolio against the ISEQ Index. It was formerly known as Irish Investment Fund Inc. The New Ireland Fund, Inc. was formed on December 14, 1989 and is domiciled in the United States.
